Technology
Health
Pharmaceutical

Dova Pharmaceuticals

$14.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.30 (-2.02%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell DOVA and other stocks, options, ETFs, and crypto commission-free!

About DOVA

Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Read More Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC.

Employees
115
Headquarters
Durham, North Carolina
Founded
2016
Market Cap
418.21M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
250.63K
High Today
$15.08
Low Today
$14.49
Open Price
$14.87
Volume
185.63K
52 Week High
$26.49
52 Week Low
$5.62

Collections

Technology
Health
Pharmaceutical
Medical
2017 IPO
US
North America

DOVA Earnings

-$0.81
-$0.66
-$0.51
-$0.36
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.57 per share
Actual
-$0.60 per share

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.